BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1106 related articles for article (PubMed ID: 24172333)

  • 1. MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
    Ling H; Fabbri M; Calin GA
    Nat Rev Drug Discov; 2013 Nov; 12(11):847-65. PubMed ID: 24172333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.
    Çetinkaya M; Baran Y
    Curr Pharm Biotechnol; 2023; 24(7):913-925. PubMed ID: 35927824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in cancer therapy resistance and targeted drug development.
    Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
    J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs: the cancer genome dark matter that matters!
    Ling H; Girnita L; Buda O; Calin GA
    Clin Chem Lab Med; 2017 May; 55(5):705-714. PubMed ID: 27988500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.
    Zhao R; Fu J; Zhu L; Chen Y; Liu B
    J Hematol Oncol; 2022 Feb; 15(1):14. PubMed ID: 35123522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs as therapeutic targets in hepatocellular cancer.
    Braconi C; Patel T
    Curr Cancer Drug Targets; 2012 Nov; 12(9):1073-80. PubMed ID: 22873215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eukaryotic non-coding RNAs: new targets for diagnostics and therapeutics?
    Rossbach O; Bindereif A
    Pharmazie; 2016 Jan; 71(1):3-7. PubMed ID: 26867346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs and new opportunities for the private sector.
    Costa FF
    Drug Discov Today; 2009 May; 14(9-10):446-52. PubMed ID: 19429503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias.
    Nguyen LD; Chau RK; Krichevsky AM
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
    Taucher V; Mangge H; Haybaeck J
    Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA: potential targets for the development of novel drugs?
    Wu W
    Drugs R D; 2010; 10(1):1-8. PubMed ID: 20509710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments.
    To KKW; Fong W; Tong CWS; Wu M; Yan W; Cho WCS
    Expert Opin Drug Discov; 2020 Jan; 15(1):63-83. PubMed ID: 31739699
    [No Abstract]   [Full Text] [Related]  

  • 17. Functions of non-coding RNAs in regulating cancer drug targets.
    Chai B; Ma Z; Wang X; Xu L; Li Y
    Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):279-291. PubMed ID: 35538038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.
    Li L; Wu P; Wang Z; Meng X; Zha C; Li Z; Qi T; Zhang Y; Han B; Li S; Jiang C; Zhao Z; Cai J
    J Hematol Oncol; 2020 Feb; 13(1):15. PubMed ID: 32111231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles for Noncoding RNAs in Autoimmune Thyroid Disease.
    Yin L; Zeng C; Yao J; Shen J
    Endocrinology; 2020 Aug; 161(8):. PubMed ID: 32270194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.
    Hassan MQ; Tye CE; Stein GS; Lian JB
    Bone; 2015 Dec; 81():746-756. PubMed ID: 26039869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.